Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial R ...
Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 ...
CEO Thomas Equels discusses recent clinical progress, upcoming milestones and the Company's commitment to advancing Ampligen® for patients with pancreatic cancer ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
The Federal Government launches phase two of the TVET programme, enhancing skills for young Nigerians, boosting employability ...
This secular, queer friendly addiction recovery group presents July opportunities. A weekly support group meets every Monday ...
[6] All States Would Face Significant Increased Costs, Many Would Owe Far More Since SNAP’s start in its current form nearly 50 years ago, the federal government has fully funded the cost of SNAP food ...
LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...
The Securities and Exchange Commission (SEC) is proposing to make significant changes to the eligibility of issuers to utilize Securities ...
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive ...
According to the National Coalition Against Domestic Violence, 1 in 3 women and 1 in 4 men have experienced some form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results